Short answer
Orthofix Medical Inc. (OFIX) filed its Q3 2025 10-Q quarterly report on Nov 4, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $206M (up 4.6% year over year) with net income of −$23M.
Q3 2025 key financials · XBRL
- Revenue
- $206M
- +4.6% YoY · +1.2% QoQ
- Net income
- −$23M
- +16.8% YoY · −61.9% QoQ
- Operating margin
- -8.3%
- Gross margin
- 72.2%
- EPS (diluted)
- −$0.57
- +19.7% YoY · −58.3% QoQ
Source: XBRL data from the Orthofix Medical Inc. (OFIX) Q3 2025 10-Q on SEC EDGAR. USD.
Orthofix Medical Inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No risk-factors section provided in the supplied excerpt
- No newly added or materially changed risks identifiable from the excerpt
- No regulatory, legal, compliance, operational, competitive, market, or financial risks disclosed in the excerpt
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Orthofix Medical Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.